
Guideline Profile : Asthma
You are here : Home > Formulary Search > Guideline Profile : Asthma
Documentation
Drugs
Below are listed all drugs that are used to treat Asthma.
- Beclometasone (Clenil Modulite)
- Beclometasone (Easyhaler)
- Beclometasone (Qvar Autohaler)
- Beclometasone (Qvar Easi-Breathe)
- Beclometasone (Qvar)
- Beclometasone with formoterol (Fostair NEXThaler)
- Beclometasone with formoterol (Fostair)
- Beclometasone with formoterol (Proxor)
- Beclometasone with formoterol and glycopyrronium (Trimbow)
- Budesonide (Budelin Novolizer)
- Budesonide (Easyhaler Budesonide)
- Budesonide (Pulmicort Turbohaler)
- Budesonide nebules
- Budesonide with formoterol (DuoResp Spiromax)
- Budesonide with formoterol (Fobumix Easyhaler)
- Budesonide with formoterol (Symbicort 100/3)
- Budesonide with formoterol (Symbicort Turbohaler)
- Dupilumab
- Fluticasone (Flixotide Accuhaler / Evohaler)
- Fluticasone with formoterol (Flutiform)
- Fluticasone with salmeterol (Combisal)
- Fluticasone with salmeterol (Fusacomb Easyhaler)
- Fluticasone with salmeterol (Seretide Accuhaler)
- Fluticasone with salmeterol (Seretide Evohaler 50/25)
- Fluticasone with salmeterol (Sirdupla)
- Fluticasone with vilanterol (Relvar Ellipta)
- Formoterol (Easyhaler)
- Formoterol (Oxis Turbohaler)
- Ipratropium (Nebules)
- Mometasone furoate with glycopyrronium bromide and indacaterol (Enerzair Breezhaler)
- Montelukast
- Salbutamol (Easyhaler)
- Salbutamol (nebules)
- Salbutamol (oral / injection)
- Salbutamol (Salamol Easi-Breathe)
- Salbutamol (Salamol)
- Salbutamol (Salbulin Novolizer)
- Salbutamol (Ventolin Accuhaler)
- Salbutamol (Ventolin Evohaler)
- Salmeterol (Serevent Evohaler / Serevent Accuhaler)
- Terbutaline (Bricanyl Turbohaler)
- Terbutaline (nebules / injection)
- Theophylline
- Tiotropium bromide (Spiriva Respimat)
Committee Recommendations (2)
The APC approved the new asthma pathways for:
- Adults and Over 12 years
- Children and young people (5-11 years)
The use of High Dose Inhaled Corticosteroid (ICS) Safety Cards are recommended for use as appropriate.
Spacer devices are recommended for use with Metered Dose Inhalation (MDI) devices.
Branded prescribing of corticosteroid inhalers is recommended following the increase in the range of inhaler devices now available. Patients should be prescribed an inhaler that meets their individual needs - where there is more than one option available, the brand with the lowest acquisition cost is recommended.
Patient education videos and instruction leaflets on the correct use of their inhaler devices can be found on the PAD page for all formulary devices.
Duplicate prescribing of inhalers that contain the same medicine is a commonly reported medicines safety incident when a patient’s inhalers are changed. The “Know your inhalers” diagram shows practice staff the class of medicine in commonly prescribed inhalers and will help to identify if there is potential for a duplicate inhaler prescribing error.